Non-small cell lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer.
Full article >>
Sunday, August 2, 2009
Study finds that lung cancer patients respond to erlotinib following cetuximab therapy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment